Project Details
Description
A Multi-Center, Open-Label BMN-110 US Expanded Access Program (BMN 110 US EAP) to Provide BMN 110 to Patients Diagnosed with MPS IVA
| Status | Finished |
|---|---|
| Effective start/end date | 12/31/13 → 11/30/14 |
Funding
- BIOMARIN PHARMACEUTICAL, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.